# Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

> **NCT01073436** · — · TERMINATED · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 7 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **OTHER:** Discontinuation of therapy

## Key facts

- **NCT ID:** NCT01073436
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Closed prematurely due to low accrual.
- **Last updated:** 2016-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01073436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01073436, "Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01073436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*